Showing results (191-200 of 710) with videos related to
Sort By:
Pageof 71
Circulation|September 1, 1990
Adrenergic receptors and sensitization of adenylyl cyclase in acute myocardial ischemiaR H Strasser, R Marquetant, W KüblerEuropean Urology|September 23, 2003
Modified laparoscopic nephroureterectomy for treatment of upper urinary tract transitional cell cancer is not associated with an increased risk of tumour recurrenceH C Klingler, M Lodde, A Pycha, et al.Investigative Urology|January 1, 1981
The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormonesG Bartsch, M Oberholzer, H P RohrDer Urologe. Ausg. A|September 1, 1991
[The potential hormonal therapy of prostatic carcinoma]U E Studer, J Altwein, G BartschEuropean Urology|April 15, 2000
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasiaG Bartsch, R S Rittmaster, H KlockerWorld Journal of Urology|May 23, 2002
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasiaG Bartsch, R S Rittmaster, H KlockerAndrologia|January 1, 1977
The effect of a synthetic progestine on the fine structure of the epididymal head (stereological analysis)G Bartsch, I Wagner, H P RohrZeitschrift Fur Geburtshilfe Und Perinatologie|October 1, 1976
[Lipid composition in placental homogenates of mature, premature and small for gestational age newborns (author's transl)]B Liedtke, G Bartsch, J P LöhrUrological Research|May 30, 1975
Ultrastructural-morphometric analysis of the rat prostate (ventral lobe)G Bartsch, E Fischer, H P RohrDer Urologe. Ausg. A|November 13, 2002
[Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia]G Bartsch, R S Rittmaster, H KlockerPageof 71